HIV resistance testing helps healthcare professionals understand whether the human immunodeficiency virus has developed changes that reduce the effectiveness of certain antiretroviral medicines. These results can guide treatment selection, particularly when a person is beginning therapy or experiencing a detectable viral load while taking medication. Choosing appropriate HIV medicines involves reviewing resistance mutations, previous treatment history, current viral load, potential drug interactions, and other clinical considerations. Understanding how resistance results influence treatment decisions can help patients participate in informed discussions with their healthcare teams. Regular monitoring and adherence to prescribed therapy remain important components of long-term HIV management.
HIV treatment has advanced significantly with the development of antiretroviral therapy (ART), which uses medicines to suppress viral replication. However, HIV can develop resistance to particular medicines when genetic changes affect how those drugs work. Resistance testing provides valuable information that helps healthcare professionals select an effective combination of medicines. Treatment decisions should always consider an individual's medical history, laboratory findings, and clinical needs rather than relying on a single test result.
HIV resistance testing identifies genetic changes in the virus that may reduce its susceptibility to specific antiretroviral medicines. These changes, known as resistance mutations, can affect different drug classes, including integrase inhibitors, protease inhibitors, and nucleoside or non-nucleoside reverse transcriptase inhibitors.
Healthcare professionals generally use resistance results alongside viral load measurements and treatment history. Genotypic testing is commonly used to identify mutations, while phenotypic testing measures how effectively HIV responds to particular medicines under laboratory conditions.
Important considerations when interpreting resistance results include:
Resistance mutations: Specific genetic changes can indicate reduced susceptibility to certain HIV medicines.
Previous treatment history: Earlier medications and documented treatment failures can influence current treatment choices.
Viral load levels: Viral load testing helps assess how well treatment is suppressing HIV.
Testing limitations: Resistance tests may not detect every previously developed mutation, especially when resistant viral populations are no longer prominent.
Treatment adherence: Missed doses, difficulty following a regimen, and drug interactions can contribute to treatment failure and should be assessed.
Resistance results require clinical interpretation. A mutation does not necessarily mean that every medicine in the same class will be ineffective, because the effects depend on the specific mutation and the drug involved.
Healthcare professionals use resistance results to develop an individualized ART regimen intended to achieve and maintain viral suppression. The selection process considers which medicines are likely to remain active against the virus and whether the proposed combination is appropriate for the individual's overall health.
Several factors can influence these decisions:
Selecting active medicines: Clinicians prioritize drugs expected to retain activity against the identified viral strain.
Considering combination therapy: Treatment generally combines multiple antiretroviral medicines to suppress viral replication and reduce the risk of additional resistance.
Reviewing drug interactions: Other prescription medicines, supplements, and certain foods can affect how HIV medicines work.
Assessing safety and tolerability: Kidney function, liver health, other medical conditions, and potential adverse effects may influence regimen selection.
Monitoring treatment response: Follow-up viral load testing helps determine whether the chosen regimen is achieving the intended results.
Resistance testing is particularly important when treatment failure is suspected. A detectable viral load does not automatically establish drug resistance. Healthcare professionals may also investigate missed doses, absorption problems, interactions, and other possible causes.
Patients should not stop, change, or replace HIV medicines without consulting their healthcare provider. If resistance is identified, the clinician may recommend a revised regimen based on the available results and treatment history.
Effective HIV management involves combining resistance testing with regular monitoring, consistent medication use, and ongoing communication between patients and healthcare professionals. With appropriate treatment selection, many people living with HIV can achieve sustained viral suppression and maintain long-term health